Gossamer Bio GOSS
NASDAQ GOSS
$10.77 -0.16 (-1.46%)
As of: Oct 2, 2026 · 1:03 PM EDT

Gossamer Bio (GOSS) Depreciation & Amortization (CF) (2018 - 2026)

Updated

Gossamer Bio (GOSS) reported Depreciation & Amortization (CF) of $5,000 for Q1 2026, down 16.7% from $6,000 a year earlier and down 16.7% from the prior quarter.

Analysis

Gossamer Bio (GOSS) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

Over the twelve months ended Mar 31, 2026, Gossamer Bio's Depreciation & Amortization (CF) came in at $23,000, down 96.3% year-over-year; for FY2025, it was $24,000, down 97.1% from FY2024.

  • Depreciation & Amortization (CF) has declined for three consecutive years, with a five-year compound annual growth rate of -55.7% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $833,000 in FY2024 (-48.2%), $1.61 million in FY2023 (-12.3%), $1.83 million in FY2022 (+5.3%) and $1.74 million in FY2021 (+23.5%).
  • The Q1 2026 figure ranks as the lowest quarterly Depreciation & Amortization (CF) in data going back to Q1 2018.
  • Year over year, Depreciation & Amortization (CF) has now declined in each of the last 11 quarters, with an average decline of 69.6% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q3 2021 (growth of 37.0%); the low point was Q2 2025 (a decline of 98.0%).
  • Per Business Quant data, the three quarters before Q1 2026 came in at $6,000 (Q4 2025), $6,000 (Q3 2025) and $6,000 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Gossamer Bio 47.40 Mn -425.99 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 5,000.00
Dec 31, 2025 6,000.00
Sep 30, 2025 6,000.00
Jun 30, 2025 6,000.00
Mar 31, 2025 6,000.00
Dec 31, 2024 108,000.00
Sep 30, 2024 200,000.00
Jun 30, 2024 300,000.00
Mar 31, 2024 259,000.00
Dec 31, 2023 292,000.00
Sep 30, 2023 400,000.00
Jun 30, 2023 500,000.00
Mar 31, 2023 500,000.00
Dec 31, 2022 432,000.00
Sep 30, 2022 500,000.00
Jun 30, 2022 500,000.00
Mar 31, 2022 500,000.00
Dec 31, 2021 440,000.00
Sep 30, 2021 500,000.00
Jun 30, 2021 400,000.00
API Access

Gossamer Bio Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=GOSS&period=max&api_key=YOUR_API_KEY